Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
Journal of Experimental Medicine · 07.10.2024 · 221 (10)
DOI: 10.1084/jem.20240637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.09.2024. Verfasst von Adrian Gervais und 34 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker …. Hauptthemen laut MEDLINE: Encephalitis, Tick-Borne, Interferon Type I, Autoantibodies, Antibodies, Neutralizing. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strasbourg University, French Foundation for Medical Research, Rockefeller University.
Abstract (Originalsprache)
Tick-borne encephalitis (TBE) virus (TBEV) is transmitted to humans via tick bites. Infection is benign in >90% of the cases but can cause mild (<5%), moderate (<4%), or severe (<1%) encephalitis. We show here that ∼10% of patients hospitalized for severe TBE in cohorts from Austria, Czech Republic, and France carry auto-Abs neutralizing IFN-α2, -β, and/or -ω at the onset of disease, contrasting with only ∼1% of patients with moderate and mild TBE. These auto-Abs were found in two of eight patients who died and none of 13 with silent infection. The odds ratios (OR) for severe TBE in individuals with these auto-Abs relative to those without them in the general population were 4.9 (95% CI: 1.5–15.9, P < 0.0001) for the neutralization of only 100 pg/ml IFN-α2 and/or -ω, and 20.8 (95% CI: 4.5–97.4, P < 0.0001) for the neutralization of 10 ng/ml IFN-α2 and -ω. Auto-Abs neutralizing type I IFNs accounted for ∼10% of severe TBE cases in these three European cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
- Imagine Institute, Paris Cité University , Paris, France.
- Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic.
- Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- Institute of Parasitology, Biology Centre of the Czech Academy of Science , České Budějovice, Czech Republic.
- Department of Children's Infectious Diseases, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
ORCID-Profile: Adrian Gervais, Astrid Marchal, Andrea Fortova, Michaela Berankova, Lenka Krbkova, Martina Pychova, Jiri Salat, Shuxiang Zhao, Nacim Kerrouche, Tom Le Voyer, Karin Stiasny, Simon Raffl, Anne Schieber Pachart, Samira Fafi-Kremer, Simon Gravier, Davide F Robbiani, Laurent Abel, Margaret R MacDonald, Charles M Rice, Gaia Weissmann, Tarek Kamal Eldin, Eva Robatscher, Elke Maria Erne, Elisabetta Pagani, Alessandro Borghesi, Anne Puel, Paul Bastard, Aurélie Velay, Martin Martinot, Yves Hansmann, Judith H Aberle, Daniel Ruzek, Aurélie Cobat, Shen-Ying Zhang, Jean-Laurent Casanova
Förderung
- Strasbourg University
- French Foundation for Medical Research
- Rockefeller University
- Meyer Foundation
- European Union
- Italian Ministry of Health
- Agence Nationale de la Recherche
- San Matteo Hospital
Zitieren
APA
Gervais, A., Marchal, A., Fortova, A., Berankova, M., Krbkova, L., Pychova, M., Salat, J., Zhao, S., Kerrouche, N., Le Voyer, T., Stiasny, K., Raffl, S., Schieber Pachart, A., Fafi-Kremer, S., Gravier, S., Robbiani, D. F., Abel, L., MacDonald, M. R., Rice, C. M., …, & Casanova, J. L. (2024). Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients. Journal of Experimental Medicine, 221(10). https://doi.org/10.1084/jem.20240637
Vancouver
Gervais A, Marchal A, Fortova A, Berankova M, Krbkova L, Pychova M, et al. Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients. Journal of Experimental Medicine. 2024;221(10). doi:10.1084/jem.20240637
BibTeX
@article{Gervais2024,
author = {Gervais, Adrian and Marchal, Astrid and Fortova, Andrea and Berankova, Michaela and Krbkova, Lenka and Pychova, Martina and Salat, Jiri and Zhao, Shuxiang and Kerrouche, Nacim and Le Voyer, Tom and Stiasny, Karin and Raffl, Simon and Schieber Pachart, Anne and Fafi-Kremer, Samira and Gravier, Simon and Robbiani, Davide F and Abel, Laurent and MacDonald, Margaret R and Rice, Charles M and Weissmann, Gaia and Kamal Eldin, Tarek and Robatscher, Eva and Erne, Elke Maria and Pagani, Elisabetta and Borghesi, Alessandro and Puel, Anne and Bastard, Paul and Velay, Aurélie and Martinot, Martin and Hansmann, Yves and Aberle, Judith H and Ruzek, Daniel and Cobat, Aurélie and Zhang, Shen-Ying and Casanova, Jean-Laurent},
title = {Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {10},
doi = {10.1084/jem.20240637}
}
EUVIMED